STDs
The firm expects its assay development collaboration with Korea's Osang Healthcare to also boost manufacturing and distribution.
Roche Gets 510(k) Clearance, CLIA Waiver for Liat Triplex Point-of-Care STI Test
The point-of-care assay to detect and differentiate chlamydia, gonorrhea, and mycoplasma infections from a single sample will now be commercially available in the US in coming months.
MedMira Receives Health Canada Approval for Point-of-Care HIV Test
The test detects HIV-1/2 antibodies in finger prick samples and is intended for use by healthcare professionals in any healthcare setting.
MedMira Nabs Health Canada Approval for POC HIV, Syphilis Assay
The Nova Scotia-based firm's Multiplo Rapid TP/HIV Test is used to detect antibodies to HIV 1/2 and syphilis in a finger prick blood sample.
Through Agency-Funded Contractors, NIAID Aims to Help Bring Infectious Disease Tests to Market
Premium
The Diagnostics Development Services program is, so far, being used to help point-of-care testing firm Fluxergy bring to market a test for sexually transmitted infections.